- Business Wire•2 days ago
Dr. Reddy’s Laboratories Ltd. announced today that it has entered into a strategic collaboration with Gland Pharma, a globally recognized developer and manufacturer of sterile dosage forms, to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications .
- Business Wire•3 days ago
Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the second quarter and half year ended September 30, 2016 under International Financial Reporting Standards .
- Business Wire•14 days agoDr. Reddy's to Release Q2 FY17 Results on Oct 25, 2016; Earnings Call Slated for Oct 25, 6.30 PM IST / 9.00 AM EDT
Dr. Reddy's Laboratories will announce results for the Second Quarter ended September 30, 2016 on Tuesday, October 25, 2016 after the Board Meeting.
Dr. Reddy's Laboratories Ltd. (DRREDDY.NS)
NSE - NSE Delayed Price. Currency in INR
|Day's Range||3,316.70 - 3,399.90|
|52wk Range||2,750.05 - 4,379.20|
|1y Target Est||N/A|
|P/E Ratio (ttm)||29.04|
|Avg Vol (3m)||269,792|
|Dividend & Yield||N/A (N/A)|